- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 578276, 6 pages
Persistence or Clearance of Human Papillomavirus Infections in Women in Ouro Preto, Brazil
1Laboratório de Genética, Instituto Butantan, Avenida Vital Brasil 1500, 05503-900 São Paulo, SP, Brazil
2Departamento de Análises Clínicas Escola de Farmácia, Universidade de Ouro Preto (UFOP), Rua Costa Sena 171, 35400-000 Ouro Preto, MG, Brazil
3Laboratório de Tocoginecologia, Departamento de Ginecologia, Universidade Federal de São Paulo, 04039-032 São Paulo, SP, Brazil
4Laboratório de Imunopatologia Keizo Asami (LIKA), Universidade Federal de Pernambuco (UFPE), 50670-901 Recife, PE, Brazil
5Programa de Pós-Graduação Interunidades em Biotecnologia, Universidade de São Paulo, 05508-900 São Paulo, SP, Brazil
6Departamento de Biologia, Universidade Federal da Integração Latino-Americana (UNILA), 85867-970 Foz do Iguaçú, PR, Brazil
Received 2 April 2013; Accepted 6 September 2013
Academic Editor: Marcelo Palma Sircili
Copyright © 2013 P. M. Miranda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- H. Z. Hausen, “Papillomaviruses and cancer: from basic studies to clinical application,” Nature Reviews Cancer, vol. 2, no. 5, pp. 342–350, 2002.
- M. Steben and E. Duarte-Franco, “Human papillomavirus infection: epidemiology and pathophysiology,” Gynecologic Oncology, vol. 107, no. 2, pp. S2–S5, 2007.
- H. Z. Hausen, “Human papillomavirus and cervical cancer,” Indian Journal of Medical Research, vol. 130, no. 3, p. 209, 2009.
- M. Schiffman, N. Wentzensen, S. Wacholder, W. Kinney, J. C. Gage, and P. E. Castle, “Human papillomavirus testing in the prevention of cervical cancer,” Journal of the National Cancer Institute, vol. 103, no. 5, pp. 368–383, 2011.
- P. E. Gravitt, “The known unknowns of HPV natural history,” Journal of Clinical Investigation, vol. 121, no. 12, pp. 4593–4599, 2011.
- X. Castellsagué and N. Muñoz, “Chapter 3: cofactors in human papillomavirus carcinogenesis—role of parity, oral contraceptives, and tobacco smoking,” Journal of the National Cancer Institute Monographs, no. 31, pp. 20–28, 2003.
- L. A. Dahlström, K. Andersson, T. Luostarinen et al., “Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 20, no. 12, pp. 2541–2550, 2011.
- H. Yetimalar, B. Kasap, K. Cukurova, A. Yildiz, A. Keklik, and F. Soylu, “Cofactors in human papillomavirus infection and cervical carcinogenesis,” Archives of Gynecology and Obstetrics, vol. 285, no. 3, pp. 805–810, 2012.
- K. E. Jensen, S. Schmiedel, B. Norrild, K. Frederiksen, T. Iftner, and S. K. Kjaer, “Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: a 13-year follow-up,” The British Journal of Cancer, vol. 108, no. 1, pp. 234–239, 2013.
- K. Syrjänen, “Mechanisms and predictors of high-risk human papillomavirus (HPV) clearance in the uterine cervix,” European Journal of Gynaecological Oncology, vol. 28, no. 5, pp. 337–351, 2007.
- M. Confortini, F. Carozzi, M. Zappa et al., “Human papillomavirus infection and risk factors in a cohort of Tuscan women aged 18–24: results at recruitment,” BMC Infectious Diseases, vol. 10, article 157, 2010.
- M. L. Sammarco, I. Del Riccio, M. Tamburro, G. M. Grasso, and G. Ripabelli, “Type-specific persistence and associated risk factors of human papillomavirus infections in women living in central Italy,” European Journal of Obstetrics and Gynecology and Reproductive Biology, vol. 168, no. 2, pp. 222–226, 2013.
- P. M. Miranda, B. C. Pitol, M. S. Moran et al., “Human papillomavirus infection in Brazilian women with normal cervical cytology,” Genetics and molecular research, vol. 11, no. 2, pp. 1752–1761, 2012.
- M. H. Schiffman, H. M. Bauer, A. T. Lorincz et al., “Comparison of Southern blot hybridization and polymerase chain reaction methods for the detection of human papillomavirus DNA,” Journal of Clinical Microbiology, vol. 29, no. 3, pp. 573–577, 1991.
- W. G. Qu, G. Jiang, Y. Cruz et al., “PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems,” Journal of Clinical Microbiology, vol. 35, no. 6, pp. 1304–1310, 1997.
- H. U. Bernard, S. Y. Chan, M. M. Manos et al., “Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms,” Journal of Infectious Diseases, vol. 170, no. 5, pp. 1077–1085, 1994.
- B. C. V. Pitol, P. M. Miranda, M. S. Moran et al., “Prevalence of HPV infection and risk factors in rural and urban women,” Unpublished results.
- E. L. Franco, L. L. Villa, J. P. Sobrinho et al., “Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer,” Journal of Infectious Diseases, vol. 180, no. 5, pp. 1415–1423, 1999.
- C. B. J. Woodman, S. Collins, H. Winter et al., “Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study,” The Lancet, vol. 357, no. 9271, pp. 1831–1836, 2001.
- N. Muñoz, F. Méndez, H. Posso et al., “Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results,” Journal of Infectious Diseases, vol. 190, no. 12, pp. 2077–2087, 2004.
- C. Banura, S. Sandin, L. van Doorn et al., “Type-specific incidence, clearance and predictors of cervical human papillomavirus infections (HPV) among young women: a prospective study in Uganda,” Infectious Agents and Cancer, vol. 5, no. 1, article 7, 2010.
- Y. Guo, K. You, J. Qiao, Y. Zhao, C. Liu, and L. Geng, “Natural history of infections with high-risk HPV in Chinese women with abnormal cervical cytology findings at baseline,” International Journal of Gynecology and Obstetrics, vol. 110, no. 2, pp. 137–140, 2010.
- M. I. Rosa, J. M. G. Fachel, D. D. Rosa, L. R. Medeiros, C. N. Igansi, and M. C. Bozzetti, “Persistence and clearance of human papillomavirus infection: a prospective cohort study,” The American Journal of Obstetrics and Gynecology, vol. 199, no. 6, pp. 617.e1–617.e7, 2008.
- E. R. Howe, Z. Li, R. C. McGlennen, W. L. Hellerstedt, and L. S. Downs Jr., “Type-specific prevalence and persistence of human papillomavirus in women in the United States who are referred for typing as a component of cervical cancer screening,” The American Journal of Obstetrics and Gynecology, vol. 200, no. 3, pp. 245.e1–245.e7, 2009.
- X. Carcopino, N. Bolger, M. Henry et al., “Evaluation of type-specific HPV persistence and high-risk HPV viral load quantitation in HPV positive women under 30 with normal cervical cytology,” Journal of Medical Virology, vol. 83, no. 4, pp. 637–643, 2011.
- C. E. Schmeink, L. F. Massuger, C. H. Lenselink et al., “Prospective follow-up of 2, 065 young unscreened women to study human papillomavirus incidence and clearance,” International Journal of Cancer, vol. 133, no. 1, pp. 172–181, 2013.
- A. Nielsen, S. K. Kjaer, C. Munk, M. Osler, and T. Iftner, “Persistence of high-risk human papillomavirus infection in a population-based cohort of Danish women,” Journal of Medical Virology, vol. 82, no. 4, pp. 616–623, 2010.
- H. Trottier, S. Mahmud, J. C. M. Prado et al., “Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination,” Journal of Infectious Diseases, vol. 197, no. 10, pp. 1436–1447, 2008.
- P. E. Castle, A. C. Rodríguez, R. D. Burk et al., “Long-term persistence of prevalently detected human papillomavirus infections in the absence of detectable cervical precancer and cancer,” Journal of Infectious Diseases, vol. 203, no. 6, pp. 814–822, 2011.
- S. Syrjänen, I. Shabalova, N. Petrovichev et al., “Factors predicting persistence of high-risk human papillomavirus (HPV) infections in women prospectively followed-up in three new independent states (NIS) of the former Soviet Union,” European Journal of Gynaecological Oncology, vol. 26, no. 5, pp. 491–498, 2005.
- E. Fukuchi, G. F. Sawaya, M. Chirenje et al., “Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in zimbabwe,” Sexually Transmitted Diseases, vol. 36, no. 5, pp. 305–311, 2009.
- N. Muoz, G. Hernandez-Suarez, F. Méndez et al., “Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women,” The British Journal of Cancer, vol. 100, no. 7, pp. 1184–1190, 2009.
- N. Muñoz and R. Herrero, “Prevention of cervical cancer in women's hands: Mexico leads the way,” The Lancet, vol. 378, no. 9806, pp. 1829–1831, 2011.
- J. Bae, S. Seo, Y. Park et al., “Natural history of persistent high-risk human papillomavirus infections in Korean women,” Gynecologic Oncology, vol. 115, no. 1, pp. 75–80, 2009.